These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11914532)

  • 1. Thrombolytic therapy in acute ischaemic stroke.
    Thomassen L; Waje-Andreassen U; Morsund AH; Hordnes J; Maintz C; Smievoll AI; Russell D
    Cerebrovasc Dis; 2002; 13(3):163-7. PubMed ID: 11914532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombolytic therapy in acute cerebral infarction].
    Thomassen L; Waje-Andreassen U; Naess H; Moen G; Smievoll AI
    Tidsskr Nor Laegeforen; 2002 Sep; 122(21):2095-7. PubMed ID: 12555643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance.
    Kharitonova T; Thorén M; Ahmed N; Wardlaw JM; von Kummer R; Thomassen L; Wahlgren N;
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):273-8. PubMed ID: 18931005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disappearance of the hyperdense MCA sign after thrombolysis: is it a predictor of better prognosis in patients with acute ischaemic stroke?
    Shuaib A
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):248. PubMed ID: 19228669
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with tPA predicts better outcome even if MCA occlusion persists.
    Kablau M; Alonso A; Hennerici MG; Fatar M
    Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DWI Lesion Patterns Predict Outcome in Stroke Patients with Thrombolysis.
    Liu D; Scalzo F; Starkman S; Rao NM; Hinman JD; Kim D; Ali LK; Saver JL; Noorian AR; Ng K; Liang C; Sheth SA; Yoo B; Liu X; Liebeskind DS;
    Cerebrovasc Dis; 2015; 40(5-6):279-285. PubMed ID: 26513397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous thrombolysis for acute ischaemic stroke in a hospital without a specialised neuro-intensive care unit.
    Wiegand N; Lüthy R; Vogel B; Straumann E; Beynon C; Bertel O; Oelz O; Caspar CB
    Swiss Med Wkly; 2004 Jan; 134(1-2):14-7. PubMed ID: 14745662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.
    Sekoranja L; Loulidi J; Yilmaz H; Lovblad K; Temperli P; Comelli M; Sztajzel RF
    Stroke; 2006 Jul; 37(7):1805-9. PubMed ID: 16763175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous thrombolysis for ischemic stroke: Experience in 54 patients].
    Guevara O C; Bulatova K; Aravena F; Caba S; Monsalve J; Lara H; Nieto E; Navarrete I; Morales M
    Rev Med Chil; 2016 Apr; 144(4):434-41. PubMed ID: 27401375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke.
    Piriyawat P; Labiche LA; Burgin WS; Aronowski JA; Grotta JC
    Stroke; 2003 May; 34(5):1242-5. PubMed ID: 12690224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of recanalization and outcome in ischemic-stroke patients treated with recombinant tissue plasminogen activator.
    Wei XE; Zhao YW; Lu J; Li MH; Li WB; Zhou YJ; Li YH
    Acta Radiol; 2015 Sep; 56(9):1119-26. PubMed ID: 25182802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute ischemic brain infarction with the assistance of local intraarterial thrombolysis with recombinant tissue-type plasminogen activator.
    Poncyljusz W; Falkowski A; Kojder I; Cebula E; Sagan L; Czechowski J; Walecka A
    Acta Radiol; 2007 Sep; 48(7):774-80. PubMed ID: 17729010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recanalization after intravenous thrombolysis: does a recanalization time window exist?
    Wunderlich MT; Goertler M; Postert T; Schmitt E; Seidel G; Gahn G; Samii C; Stolz E; ;
    Neurology; 2007 Apr; 68(17):1364-8. PubMed ID: 17452580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clot characteristics on computed tomography and response to thrombolysis in acute middle cerebral artery stroke.
    Topcuoglu MA; Arsava EM; Akpinar E
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1363-72. PubMed ID: 25804568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
    Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.